The Challenge: Hidden Exposure to Market Shocks

Finance teams are expected to explain, in near real time, how interest rate moves, FX swings or commodity shocks translate into earnings and cash flow. In reality, exposures are buried across trading systems, treasury tools, ERP modules, spreadsheets and complex contracts. By the time someone has manually stitched together positions, hedges and sensitivities, the market has often moved on — and the organisation is flying blind.

Traditional approaches rely on fragmented risk cubes, manual spreadsheet models and static reports. Exposure breakdowns are run monthly or quarterly, sensitivity tables are copied from legacy systems, and deep-dive risk analysis depends on a handful of experts who understand both the products and the data landscape. These methods simply cannot keep pace with today’s volatility, new instruments, and the volume of data — especially when hedges, natural offsets and contingent exposures are spread across business units and geographies.

The consequence is a dangerous gap between perceived and actual risk. Companies can unintentionally double up on exposures, miss concentrations in specific currencies or maturities, and underestimate how combined shocks propagate through P&L and liquidity. That leads to surprise hits on earnings, delayed hedging decisions, higher capital costs, and uncomfortable conversations with investors and boards. Competitors with better risk visibility react faster, negotiate better terms, and allocate capital with more confidence.

Yet this challenge is solvable. AI tools like Claude can read and reconcile complex risk reports, models and contract texts at a scale humans cannot, and highlight non-obvious correlations and tail risks. With Reruption’s experience building AI-powered analysis and decision-support tools inside organisations, finance teams can move from slow, manual sensitivity checks to proactive, AI-assisted market risk management. The rest of this page walks through how to do that in a practical, concrete way.

Need a sparring partner for this challenge?

Let's have a no-obligation chat and brainstorm together.

Innovators at these companies trust us:

Our Assessment

A strategic assessment of the challenge and high-level tips how to tackle it.

From Reruption’s work implementing AI solutions in complex, data-heavy environments, we see Claude as a powerful layer on top of existing risk systems rather than a replacement. For finance teams struggling with hidden exposure to market shocks, Claude can parse long risk reports, regulatory texts, portfolio analytics and contract documentation to surface patterns and propagation paths that are easy to miss in traditional tooling.

Frame Claude as an Exposure Intelligence Layer, Not a New Risk Engine

Claude should sit on top of your existing market risk and treasury systems, not replace them. Your VaR, sensitivities (DV01, CS01, FX delta, commodity betas) and position data remain the quantitative source of truth. Claude’s role is to read those outputs, connect them with qualitative information (contracts, policies, memos) and expose non-obvious concentrations, mismatches and shock propagation paths.

This framing matters for governance and adoption: risk, treasury and controllers remain accountable for methodology and numbers; Claude augments their ability to ask better questions and find issues faster. Communicating this early reduces resistance from quant and risk teams who may fear a “black box” replacing their models.

Start with a Well-Defined Shock & Scenario Library

Strategic use of Claude for market shock analysis requires a common language for scenarios. Before rolling out any AI workflows, finance leadership should define a shock and scenario library: standard rate curves (parallel shifts, twists), FX devaluations or spikes, commodity gaps, and combined stress events relevant to your business model.

Once this library is defined, you can instruct Claude to consistently analyse “what does Scenario S3 imply for next quarter EBIT by region?” instead of reinventing scenarios on the fly. This reduces ambiguity, supports comparability over time, and makes it easier to embed Claude into existing risk committee and treasury processes.

Align Risk, Treasury and Business Units Around Data Ownership

Claude can only reveal hidden exposures if it can access the right inputs. Strategically, that means clarifying who owns which data: treasury for funding and hedging positions, business units for commercial exposures, risk for limits and methodologies, and accounting for hedge designations. Without this, you end up with impressive AI analysis on incomplete data.

Finance leadership should set up a light-weight governance model defining which reports, extracts and document types Claude will process regularly (e.g., weekly FX exposure files, commodity purchase contracts, interest rate hedging summaries) and who is responsible for feeding and validating them. This avoids the common trap of an AI pilot that works technically but never becomes critical infrastructure.

Design Claude Workflows with Controls and Explainability in Mind

In a regulated function like finance, AI for market risk must be explainable and controllable. Strategically, that means designing Claude workflows where outputs are always traceable back to underlying sources: specific reports, tables or contractual clauses. Claude should help you navigate and interpret your data and documentation, not bypass them.

For example, instead of asking Claude “How big is our FX risk?” you define workflows such as “Given the attached exposure report and hedge register, list all currency pairs where unhedged exposure exceeds the approved limit, and reference the exact rows behind each finding.” This mindset enables auditability and makes risk and internal audit teams more comfortable with AI augmentation.

Prepare Teams for an Analytical Co-Pilot, Not Fully Automated Decisions

Claude is best positioned as an analytical co-pilot for finance and risk teams: scanning documents, highlighting anomalies, drafting dashboards and simulating narratives around shocks. Strategic decisions — e.g., changing hedge ratios, moving limit structures, or adjusting capital allocation — stay with humans. Expecting Claude to make these decisions autonomously is both unrealistic and risky.

Set expectations accordingly: initially, success is measured by faster insight generation, more consistent sensitivity analysis, and earlier identification of concentrations. Over time, as comfort grows and patterns stabilise, you can selectively automate parts of the process (e.g., weekly exposure summaries) with clearly defined human review points.

Used with the right framing and controls, Claude can turn scattered exposure data, complex instruments and long risk reports into actionable insight on market shocks. Instead of scrambling to assemble spreadsheets after a rate or FX move, your team can rely on an AI co-pilot that continuously surfaces concentrations, tail risks and propagation paths. With Reruption’s Co-Preneur approach and hands-on engineering depth, we can help you design, prototype and embed these Claude workflows directly into your finance processes — if you’re exploring this, reach out and we can test a concrete use case together in a focused PoC.

Need help implementing these ideas?

Feel free to reach out to us with no obligation.

Real-World Case Studies

From Healthcare to Fintech: Learn how companies successfully use Claude.

Stanford Health Care

Healthcare

Stanford Health Care, a leading academic medical center, faced escalating clinician burnout from overwhelming administrative tasks, including drafting patient correspondence and managing inboxes overloaded with messages. With vast EHR data volumes, extracting insights for precision medicine and real-time patient monitoring was manual and time-intensive, delaying care and increasing error risks. Traditional workflows struggled with predictive analytics for events like sepsis or falls, and computer vision for imaging analysis, amid growing patient volumes. Clinicians spent excessive time on routine communications, such as lab result notifications, hindering focus on complex diagnostics. The need for scalable, unbiased AI algorithms was critical to leverage extensive datasets for better outcomes.

Lösung

Partnering with Microsoft, Stanford became one of the first healthcare systems to pilot Azure OpenAI Service within Epic EHR, enabling generative AI for drafting patient messages and natural language queries on clinical data. This integration used GPT-4 to automate correspondence, reducing manual effort. Complementing this, the Healthcare AI Applied Research Team deployed machine learning for predictive analytics (e.g., sepsis, falls prediction) and explored computer vision in imaging projects. Tools like ChatEHR allow conversational access to patient records, accelerating chart reviews. Phased pilots addressed data privacy and bias, ensuring explainable AI for clinicians.

Ergebnisse

  • 50% reduction in time for drafting patient correspondence
  • 30% decrease in clinician inbox burden from AI message routing
  • 91% accuracy in predictive models for inpatient adverse events
  • 20% faster lab result communication to patients
  • Improved autoimmune detection by 1 year prior to diagnosis
Read case study →

Cleveland Clinic

Healthcare

At Cleveland Clinic, one of the largest academic medical centers, physicians grappled with a heavy documentation burden, spending up to 2 hours per day on electronic health record (EHR) notes, which detracted from patient care time. This issue was compounded by the challenge of timely sepsis identification, a condition responsible for nearly 350,000 U.S. deaths annually, where subtle early symptoms often evade traditional monitoring, leading to delayed antibiotics and 20-30% mortality rates in severe cases. Sepsis detection relied on manual vital sign checks and clinician judgment, frequently missing signals 6-12 hours before onset. Integrating unstructured data like clinical notes was manual and inconsistent, exacerbating risks in high-volume ICUs.

Lösung

Cleveland Clinic piloted Bayesian Health’s AI platform, a predictive analytics tool that processes structured and unstructured data (vitals, labs, notes) via machine learning to forecast sepsis risk up to 12 hours early, generating real-time EHR alerts for clinicians. The system uses advanced NLP to mine clinical documentation for subtle indicators. Complementing this, the Clinic explored ambient AI solutions like speech-to-text systems (e.g., similar to Nuance DAX or Abridge), which passively listen to doctor-patient conversations, apply NLP for transcription and summarization, auto-populating EHR notes to cut documentation time by 50% or more. These were integrated into workflows to address both prediction and admin burdens.

Ergebnisse

  • 12 hours earlier sepsis prediction
  • 32% increase in early detection rate
  • 87% sensitivity and specificity in AI models
  • 50% reduction in physician documentation time
  • 17% fewer false positives vs. physician alone
  • Expanded to full rollout post-pilot (Sep 2025)
Read case study →

Samsung Electronics

Manufacturing

Samsung Electronics faces immense challenges in consumer electronics manufacturing due to massive-scale production volumes, often exceeding millions of units daily across smartphones, TVs, and semiconductors. Traditional human-led inspections struggle with fatigue-induced errors, missing subtle defects like micro-scratches on OLED panels or assembly misalignments, leading to costly recalls and rework. In facilities like Gumi, South Korea, lines process 30,000 to 50,000 units per shift, where even a 1% defect rate translates to thousands of faulty devices shipped, eroding brand trust and incurring millions in losses annually. Additionally, supply chain volatility and rising labor costs demanded hyper-efficient automation. Pre-AI, reliance on manual QA resulted in inconsistent detection rates (around 85-90% accuracy), with challenges in scaling real-time inspection for diverse components amid Industry 4.0 pressures.

Lösung

Samsung's solution integrates AI-driven machine vision, autonomous robotics, and NVIDIA-powered AI factories for end-to-end quality assurance (QA). Deploying over 50,000 NVIDIA GPUs with Omniverse digital twins, factories simulate and optimize production, enabling robotic arms for precise assembly and vision systems for defect detection at microscopic levels. Implementation began with pilot programs in Gumi's Smart Factory (Gold UL validated), expanding to global sites. Deep learning models trained on vast datasets achieve 99%+ accuracy, automating inspection, sorting, and rework while cobots (collaborative robots) handle repetitive tasks, reducing human error. This vertically integrated ecosystem fuses Samsung's semiconductors, devices, and AI software.

Ergebnisse

  • 30,000-50,000 units inspected per production line daily
  • Near-zero (<0.01%) defect rates in shipped devices
  • 99%+ AI machine vision accuracy for defect detection
  • 50%+ reduction in manual inspection labor
  • $ millions saved annually via early defect catching
  • 50,000+ NVIDIA GPUs deployed in AI factories
Read case study →

Lunar

Banking

Lunar, a leading Danish neobank, faced surging customer service demand outside business hours, with many users preferring voice interactions over apps due to accessibility issues. Long wait times frustrated customers, especially elderly or less tech-savvy ones struggling with digital interfaces, leading to inefficiencies and higher operational costs. This was compounded by the need for round-the-clock support in a competitive fintech landscape where 24/7 availability is key. Traditional call centers couldn't scale without ballooning expenses, and voice preference was evident but underserved, resulting in lost satisfaction and potential churn.

Lösung

Lunar deployed Europe's first GenAI-native voice assistant powered by GPT-4, enabling natural, telephony-based conversations for handling inquiries anytime without queues. The agent processes complex banking queries like balance checks, transfers, and support in Danish and English. Integrated with advanced speech-to-text and text-to-speech, it mimics human agents, escalating only edge cases to humans. This conversational AI approach overcame scalability limits, leveraging OpenAI's tech for accuracy in regulated fintech.

Ergebnisse

  • ~75% of all customer calls expected to be handled autonomously
  • 24/7 availability eliminating wait times for voice queries
  • Positive early feedback from app-challenged users
  • First European bank with GenAI-native voice tech
  • Significant operational cost reductions projected
Read case study →

Insilico Medicine

Biotech

The drug discovery process traditionally spans 10-15 years and costs upwards of $2-3 billion per approved drug, with over 90% failure rate in clinical trials due to poor efficacy, toxicity, or ADMET issues. In idiopathic pulmonary fibrosis (IPF), a fatal lung disease with limited treatments like pirfenidone and nintedanib, the need for novel therapies is urgent, but identifying viable targets and designing effective small molecules remains arduous, relying on slow high-throughput screening of existing libraries. Key challenges include target identification amid vast biological data, de novo molecule generation beyond screened compounds, and predictive modeling of properties to reduce wet-lab failures. Insilico faced skepticism on AI's ability to deliver clinically viable candidates, regulatory hurdles for AI-discovered drugs, and integration of AI with experimental validation.

Lösung

Insilico deployed its end-to-end Pharma.AI platform, integrating generative AI and deep learning for accelerated discovery. PandaOmics used multimodal deep learning on omics data to nominate novel targets like TNIK kinase for IPF, prioritizing based on disease relevance and druggability. Chemistry42 employed generative models (GANs, reinforcement learning) to design de novo molecules, generating and optimizing millions of novel structures with desired properties, while InClinico predicted preclinical outcomes. This AI-driven pipeline overcame traditional limitations by virtual screening vast chemical spaces and iterating designs rapidly. Validation through hybrid AI-wet lab approaches ensured robust candidates like ISM001-055 (Rentosertib).

Ergebnisse

  • Time from project start to Phase I: 30 months (vs. 5+ years traditional)
  • Time to IND filing: 21 months
  • First generative AI drug to enter Phase II human trials (2023)
  • Generated/optimized millions of novel molecules de novo
  • Preclinical success: Potent TNIK inhibition, efficacy in IPF models
  • USAN naming for Rentosertib: March 2025, Phase II ongoing
Read case study →

Best Practices

Successful implementations follow proven patterns. Have a look at our tactical advice to get started.

Use Claude to Reconcile Exposures Across Systems into a Single Narrative

One of the most effective tactical uses of Claude in finance is to reconcile exposures from multiple systems into a clear story for decision-makers. Export your rate, FX and commodity exposures from treasury, ERP and trading systems (e.g., CSV or Excel summaries), and combine them with existing risk reports in a single workspace for Claude.

Then, use prompts that force Claude to both summarise and point back to sources. For example:

Act as a senior market risk analyst.
You receive multiple exposure reports from different systems:
- File A: FX exposures by currency and business unit
- File B: Interest rate exposures by currency, tenor bucket and instrument type
- File C: Commodity purchase commitments by month and supplier

Tasks:
1) Reconcile and summarise our net exposure by risk factor type
   (FX, Interest Rates, Commodities) and by region.
2) Highlight any concentrations where net unhedged exposure exceeds
   EUR 5m or where notional hedges mature more than 6 months before
   the underlying exposure.
3) For each concentration, reference the specific rows/sections in
   the input files that support your conclusion.
4) Provide a short narrative that a CFO can use to explain our
   exposure profile to the Board under current market conditions.

This approach lets you keep quantitative processing in your existing tools while using Claude to create a coherent, source-linked exposure narrative in hours instead of days.

Build Claude-Powered Shock and Sensitivity Briefings

Instead of ad-hoc shock analysis after a market move, create reusable Claude templates for shock and sensitivity briefings. Start by defining a handful of standard shocks (e.g., +200 bps parallel rate shift, 10% EUR depreciation vs. USD, 20% commodity price spike) and link them to your sensitivity outputs (DV01, FX delta, commodity betas) from risk systems.

Then configure prompts that let Claude generate concise impact assessments using the latest files:

You are preparing a market shock briefing for the Group CFO.
Inputs:
- Interest rate sensitivity report (DV01 by currency and bucket)
- FX exposure and sensitivity report
- Commodity sensitivity report

Market scenario:
- Parallel +200 bps shift in EUR interest rates
- 10% depreciation of EUR vs. USD

Tasks:
1) Quantify estimated impact on next 12 months net interest income,
   by currency and business unit.
2) Quantify estimated impact on EBIT from FX and commodity exposures.
3) Highlight top 5 risk concentrations by product, region or currency.
4) Summarise key messages in max 10 bullet points for the CFO, and
   propose 3 immediate actions to consider.
5) Flag any data limitations or inconsistencies you detect.

Save these as templates in your workflow so that, when markets move, analysts only need to refresh data exports and re-run the briefing — Claude handles the heavy lifting of synthesis and communication.

Let Claude Mine Contracts and Policies for Hidden Risk Drivers

Hidden exposure to market shocks often sits in long contracts and policies: FX clauses, commodity indexation, pricing formulas, or covenants tied to interest rates. Claude is particularly strong at reading long, complex documents and extracting relevant conditions and risk drivers.

Upload key supplier contracts, loan agreements, and commercial terms and ask Claude to extract and structure market-linked clauses:

Act as a contract analyst focusing on market risk.
Read the attached contracts and policies.

Tasks:
1) Extract all clauses that reference:
   - FX rates or FX indexation
   - Interest rates, benchmarks or rate resets
   - Commodity prices or commodity indices
2) For each clause, provide:
   - Document name and section reference
   - Description of the exposure (e.g., "price linked to Brent
     minus USD X", "interest margin resets with EURIBOR")
   - Whether the clause increases our volatility or helps us hedge.
3) Summarise where we may have unrecognised or poorly documented
   exposures to rate, FX or commodity shocks.

The output can form the basis for a structured register of contract-based exposures that you can then align with your formal risk systems.

Use Claude to Draft Early-Warning Dashboards and Risk Policies

Finance teams often know they need better dashboards and policies for market risk early warning, but creating them is time-consuming. Claude can draft initial versions based on your current reports, limits and governance documents, which you then refine.

Provide examples of existing risk reports, your risk appetite statement, and sample board materials, then ask Claude to propose dashboard structures and policy improvements:

You are designing an early-warning dashboard for market shocks.
Inputs:
- Current market risk report
- Risk appetite statement and limit framework
- Sample monthly CFO report

Tasks:
1) Propose a dashboard layout with 10-15 KPIs that would allow the
   CFO to see emerging rate, FX and commodity risks.
2) For each KPI, define:
   - Data source
   - Calculation logic
   - Thresholds for green/amber/red status
3) Draft a short policy section (max 2 pages) that defines how the
   dashboard is used in monthly risk committees, and what actions
   are triggered when thresholds are breached.

This doesn’t replace governance work, but accelerates it significantly and ensures that policies are grounded in your actual data and reporting reality.

Embed Claude Checks into Month-End and Quarterly Risk Routines

To avoid AI remaining a one-off experiment, integrate Claude-based exposure checks into month-end close and quarterly risk routines. Define a small set of recurring questions that Claude should answer each period using the latest exposure, hedge and P&L attribution reports.

For example, design a standard month-end prompt:

Using the attached month-end exposure, hedge and P&L attribution
reports, perform the following checks:

1) Identify any currencies, tenors or commodities where unhedged
   exposure increased > 25% vs. last month.
2) Highlight any new instruments or counterparties that appear
   material in this month's data.
3) Reconcile the top 5 contributors to market-related P&L with
   changes in exposures or market levels.
4) Flag any mismatches between our documented hedging strategy
   and the actual positions observed.
5) Provide a 1-page summary for inclusion in the monthly risk
   committee pack.

Over time, you can formalise this into a checklist that risk controllers run each month, with Claude’s outputs stored alongside traditional reports for auditability.

Executed this way, using Claude in the finance function can realistically cut manual exposure reconciliation and narrative-building effort by 30–50%, shorten response time to significant market moves from days to hours, and materially reduce the probability of unexpected P&L hits from misaligned or unnoticed exposures. The exact numbers will depend on your data quality and process maturity, but teams that systematically embed these workflows typically see faster risk insight and more disciplined hedging decisions within one to two quarters.

Need implementation expertise now?

Let's talk about your ideas!

Frequently Asked Questions

Claude helps by reading and connecting information that is currently scattered across your finance landscape. It can parse exposure reports, hedge registers, contracts, policies and P&L attribution and then highlight where interest rate, FX or commodity exposures don’t line up with your hedges, limits or documented strategies.

In practice, this means Claude can surface non-obvious concentrations (e.g., multiple business units all long the same currency), detect mismatches in hedge tenors, or flag contract clauses that introduce unrecognised market-linked risk — all with clear references back to the underlying data or document sections.

You don’t need a team of data scientists to start. The critical ingredients are: 1) finance and risk people who understand your exposure landscape and reporting; 2) access to key data exports and documents (risk reports, contracts, hedge logs); and 3) someone who can work with Reruption or your IT team to set up secure, compliant access to Claude.

Claude is prompt-driven, so much of the work is designing robust analysis templates and workflows rather than building complex models. Reruption typically collaborates with a small cross-functional squad (treasury/risk, controlling, IT) to stand up an initial use case in weeks, not months.

For well-scoped use cases around exposure reconciliation and shock briefings, you can usually see tangible benefits within 4–8 weeks. In the first 2–3 weeks, we focus on scoping, data access and building initial prompts on top of existing reports. Shortly after, teams start using Claude-generated summaries and dashboards in real risk meetings.

Full embedding into month-end and quarterly routines, including governance and documentation adjustments, typically happens over one to two quarters. The pace mainly depends on how quickly your organisation can align stakeholders and update processes, not on the AI technology itself.

The direct technology cost of using Claude is relatively modest compared to traditional risk systems; most of the investment is in integration, workflow design and change management. Reruption’s AI PoC at 9.900€ is designed to answer the ROI question quickly by testing a specific use case (e.g., FX exposure reconciliation and shock briefing) in a working prototype.

ROI typically comes from three sources: reduced manual analyst time spent stitching together exposures, faster and better-informed hedging decisions (avoiding surprise P&L hits), and improved transparency for boards and lenders. Many finance teams can justify the investment if Claude helps prevent even a single moderate mis-hedging error or late reaction to a market move.

Reruption works as a Co-Preneur alongside your finance and risk teams. We start with a focused AI PoC (9.900€) where we define the concrete use case (for example, uncovering FX and rate concentrations across entities), assess data and system constraints, and build a working Claude prototype on top of your real reports and documents.

From there, our engineers and product people help you turn the prototype into a robust internal tool: designing secure workflows, integrating with existing reporting, and embedding Claude outputs into your month-end and risk committee routines. Because we operate inside your P&L, not just in slide decks, the goal is always a functioning AI solution that your finance team actually uses to manage market shock risk more proactively.

Contact Us!

0/10 min.

Contact Directly

Your Contact

Philipp M. W. Hoffmann

Founder & Partner

Address

Reruption GmbH

Falkertstraße 2

70176 Stuttgart

Social Media